William Blair Issues Negative Outlook for VKTX Earnings
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Equities researchers at William Blair decreased their Q1 2025 earnings per share estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. William Blair analyst A. Hsieh now expects that the biotechnology company will post earnings of ($0.34) per share […]
